Evaluation of Toxicity and Biodegradability of Cholinium Amino Acids Ionic Liquids

If you’ve followed the story of ionic liquids, you know the promise: solvents that don’t evaporate, don’t catch fire easily, and could make industrial chemistry a little gentler on the planet. Then came the catch. Many of the classic ones built on imidazolium or pyridinium rings can be tough on enzymes, harsh on microbes, and stubborn in the environment. So chemists pivoted. Could you keep the useful solvent behavior but swap in building blocks that biology already knows how to handle? That’s where cholinium amino acid ionic liquids come in. The cholinium cation looks a lot like vitamin B4, and the anions are just amino acids. On paper, that feels greener. The real question is: do they actually behave that way when you test them? Hou, Liu, Smith, Li, and Zong set up a three-part check. First, they hit a sensitive enzyme, acetylcholinesterase, and see how much it’s inhibited. Second, they challenge a small panel of bacteria that stand in for diverse cell envelopes. Third, they hand these liquids to a mixed community of wastewater microbes and ask: do they chew them up? They didn’t stop at one or two salts. They paired cholinium with a broad sweep of amino acids: glycine, alanine, the branched ones like valine and leucine, polar ones like serine and threonine, acids and amides, basics, and aromatics like phenylalanine and tryptophan. For context, they kept two cholinium controls, chloride and acetate, and a conventional imidazolium benchmark, one-butyl-three-methylimidazolium tetrafluoroborate, that shows up all over the ionic liquid literature. Let’s talk methods without getting lost in the weeds. For the enzyme, they used a classic color readout: DTNB, sometimes called Ellman’s reagent. Acetylcholinesterase chops a thiocholine substrate; DTNB grabs the product and turns yellow; you track the rate at 405 nanometers. They buffered the assay at pH 8, held it at 37 degrees Celsius, and titrated each ionic liquid across a concentration range while keeping the enzyme concentration constant. From the inhibition curves, they pulled an EC50—the concentration that halves the enzyme’s activity—using a standard dose-response fit. They did this in triplicate, reported means and confidence intervals, and used an analysis of variance to decide when differences were real. As a sanity check, they also looked at catalase, a very different enzyme, to see if the same patterns held. The bacteria were handled with a straightforward tube-dilution approach. They grew Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, and Staphylococcus aureus to about a million cells per milliliter in Mueller–Hinton broth, added the ionic liquid, and after a day assessed whether the culture turned cloudy. No cloudiness means you’ve hit the minimal inhibitory concentration, the MIC. To ask what it takes to actually kill, not just stall growth, they plated samples on agar and looked for a thousand-fold reduction—that’s the minimum biocidal concentration, the MBC. Again, triplicates and controls were baked in. And then the big ecological test: biodegradability. They used two aerobic assays with real wastewater microbes. In the closed-bottle test that follows the Organisation for Economic Co-operation and Development’s 301D guideline, they measured how much oxygen dissolved in the water disappeared as the microbes metabolized the chemical. In the parallel carbon-dioxide headspace setup, they tracked how much carbon dioxide accumulated as ultimate evidence of mineralization. If an organic compound crosses a set threshold of mineralization within 28 days, it gets the tag “readily biodegradable.” Sodium benzoate, a textbook biodegradable compound, served as a reference to check that the bugs were happy and the tests were working. Now the part you came for: what happened. On acetylcholinesterase, the cholinium amino acid liquids were much gentler than the imidazolium benchmark, about a tenfold gap. The EC50s for the cholinium amino acid salts clustered in the low thousands of millimolar, around 2.5 to 3.9 times one thousand, whereas the imidazolium benchmark came in near 330 millimolar. Bigger EC50 means weaker inhibition. That’s good news for the cholinium family. Acetone—thrown in as a benign solvent control—didn’t reach 50 percent inhibition even at the high end of the tested window, which is also what you’d hope to see. There was nuance inside the cholinium set. The aromatic amino acids stood out as the most inhibitory: cholinium tryptophan landed near 2,450 millimolar, and cholinium phenylalanine around 2,740. Still far above imidazolium’s 330, but lower than their aliphatic cousins like glycine and alanine, which were up around 3,830 and 3,330 millimolar. Why might that be? Acetylcholinesterase has a narrow gorge lined with aromatic residues, and chemists have shown that aromatic cations can stack with tryptophan at the enzyme’s peripheral anionic site. Add an aromatic ring to the anion, and you can strengthen those interactions. On the flip side, making the side chain more polar—adding a hydroxyl, or a second carboxyl or amide—tended to ease off the inhibition. Lengthening aliphatic chains had a more complicated story: a little hydrophobicity raised potency, but making them too bulky likely created steric clashes that reduced access to the active gorge. When they checked catalase, the pattern was qualitatively similar but required concentrations six to eight hundred times higher to see the same degree of inhibition. That tells you acetylcholinesterase is simply more sensitive to this chemical family, and that the overall enzyme toxicity of these cholinium salts is modest. Turn to the bacteria, and the gap widens. The cholinium amino acid liquids generally didn’t bother the microbes until they were present at tens to low hundreds of millimolar. For E. coli, minimal inhibitory concentrations commonly sat around 31 to 125 millimolar, with the aromatic versions again on the more potent end, down in the 23 to 31 millimolar range. Across Salmonella, Listeria, and Staph, a lot of the action clustered between about 46 and 125 millimolar, with the more hydrophilic, acidic, or amide-bearing anions pushing into the high end of that range or above. By contrast, the imidazolium benchmark often shut down growth near two to three millimolar. Same chemistry, very different biological impact. Killing outright, as measured by minimal biocidal concentrations, followed the same hierarchy. A small aside: cholinium chloride and cholinium acetate, the simple anions, tended to be even less active against bacteria than the amino-acid-based salts, which suggests the side chain does matter for microbial membranes. One pattern worth pausing on: Gram-negative bacteria like E. coli and Salmonella were a bit more susceptible than the Gram-positive ones, Listeria and Staph. That’s flipped from what you might expect with some antibiotics and speaks to the different ways cations and anions can thread—or fail to thread—the double membrane of Gram-negatives versus the thick peptidoglycan wall of Gram-positives. It also lines up with the idea that hydrophobicity and aromaticity, which help you cross lipid-rich barriers, track with stronger antibacterial effects in this set. Now, biodegradation. Here, the cholinium amino acids perform like you’d hope if you’re aiming for greener solvents. All of them crossed the “readily biodegradable” line in both tests. In the closed-bottle oxygen assay, the numbers after 28 days landed between about 62 and 87 percent of theoretical oxygen demand. The carbon dioxide measurements told the same story and let you see the structural levers more clearly. If the amino acid side chain carried extra carboxyl or amide groups—think aspartate, glutamate, asparagine, glutamine—mineralization was excellent, typically around 81 to 85 percent in the headspace test and at least 86 percent overall. Unbranched, small aliphatics like glycine and alanine were also easy meals for the microbes, often around 80 to 87 percent. Make the side chain branched, as in valine, leucine, or isoleucine, and degradation slowed a bit, dipping into the high sixties to low seventies. Basic amino acids, with their extra amines, sat in the mid-sixties. The aromatic tryptophan salt, which was also more inhibitory to acetylcholinesterase and bacteria, lagged near 62 percent. It still passed, but it set the floor. That consistency created a useful map. As they plotted the data, Hou and colleagues saw that, for most cholinium amino acid salts, the less toxic ones were also the ones that biodegraded more completely. You weren’t forced into a trade-off between sparing biology today and saddling the environment tomorrow. Two classes did tend to buck the trend: the aromatics, which were a bit harsher and a bit more recalcitrant, and the branched aliphatics, which weren’t particularly toxic but were slower to mineralize. Even there, the differences were relative, not disqualifying. Every member of the family still cleared the threshold for ready biodegradation in both assays. A quick word on why this testing backbone matters. Acetylcholinesterase is a very sensitive bellwether for neurotoxicity and a convenient proxy for enzyme compatibility in bioprocessing. If a solvent barely nudges this enzyme, there’s a decent chance it will be gentler to others that matter in biomass pretreatment or biocatalysis. The microbial panel gives you a feel for acute antimicrobial action that might disrupt wastewater treatment or microbiomes. And the biodegradation assays, because they use mixed communities plucked from real wastewater plants, don’t just report a chemical’s theoretical fate. They reflect what our infrastructure can actually do with it. So, what’s the bottom line? In head-to-head tests, cholinium amino acid ionic liquids are markedly less inhibitory to a sensitive enzyme than a widely used imidazolium benchmark, by roughly an order of magnitude on the EC50 scale. They show modest antibacterial activity, with minimal inhibitory concentrations and minimal biocidal concentrations usually in the tens to hundreds of millimolar instead of the low single digits. And when you hand them to wastewater microbes, they get eaten—62 to 87 percent mineralized in 28 days, often higher for anions that present extra carboxyl or amide handles. Structure matters, and the knobs chemists can turn are clear: avoid aromatics if you want maximal gentleness and rapid breakdown; favor small, unbranched, or extra-oxygenated side chains to boost degradability. There are caveats, and the authors are frank about them. A single enzyme and four bacteria don’t cover the biosphere. Aquatic invertebrates, algae, and soil fungi are tests that still need to be run. And while the headspace carbon dioxide test tells you that carbon is ending up as carbon dioxide, it doesn’t tell you every intermediate step. Analytical tracking of breakdown pathways would help close that loop. But as a proof of greener by design, this is strong evidence. It says you can build ionic liquids from biogenic parts and keep the solvent behavior without tripping the worst biological alarms. It says you can make choices—about aromaticity, branching, and functional groups—that don’t just make the molecules nicer on paper; they make them more livable in practice. And it offers a reminder that green chemistry isn’t a slogan; it’s a set of measurements run carefully, compared fairly, and interpreted with the humility that biology teaches over and over again.